Technical / White Paper

New study of Angel® yeast beta-glucan shows efficacy in improving Alzheimer's disease by regulating gut microbiota and metabolites

Format: PDF file | Document type: Technical / White Paper | Promoted Content

This content is provided by Angel Yeast – Human Health, and any views and opinions expressed do not necessarily reflect those of www.nutraingredients.com

New study of Angel® yeast beta-glucan shows efficacy in improving Alzheimer's disease by regulating gut microbiota and metabolites

A recent study published by Angel Yeast Co., Ltd. on International Journal of Biological Macromolecules attracted much attention. Researchers found that yeast beta-glucan was related to a series of gut-brain axis events and can improve neuroinflammation and brain insulin resistance, which means that yeast beta-glucan may prevent Alzheimer's disease. This study broadened the potential applications of yeast beta-glucan as a novel dietary supplement to prevent early-stage pathologies associated with AD.

Yeast beta-glucan is a polysaccharide derived from Saccharomyces cerevisiae​, with featured molecular structure of a linear beta-(1, 3)-glucan backbone with beta-(1, 6)-linked side chains. It shows stronger biological activities than other sources of beta-glucans especially in immunity enhancing. “Nowadays, AD has become a global healthy problem, this study unveiled the relationship between yeast beta-glucan and AD, presenting a potential way to improve AD.” Said Poshy Zhang, R&D director of Angel Yeast Human Health Division.

Latest content from Angel Yeast – Human Health

show more

Yeast beta glucan to boost immunity, improve sleep quality and reduce sore throat symptoms associated with flu and common colds

Paid for and in partnership with Angel Yeast – Human Health

Flu fighters: how yeast beta-glucan can boost immunity

Study reveals beta-glucan from baker’s yeast can help to support the immune system, improve sleep quality and reduce symptoms for flu and the common cold.

Supplier info centre